Follow
alberto cantalapiedra
alberto cantalapiedra
Médico Hematólogo, hospital Universitario Río Hortega
Verified email at saludcastillayleon.es
Title
Cited by
Cited by
Year
Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction
F Fernández-Avilés, JA San Román, J García-Frade, ME Fernández, ...
Circulation research 95 (7), 742-748, 2004
6162004
The CD69 early activation molecule is overexpressed in human bone marrow mast cells from adults with indolent systemic mast cell disease
B Díaz‐Agustín, L Escribano, P Bravo, S Herrero, R Nuñez, R Navalón, ...
British journal of haematology 106 (2), 400-405, 1999
451999
Oral anticoagulant treatment: risk factors involved in 500 intracranial hemorrhages
A Cantalapiedra, O Gutierrez, JI Tortosa, M Ya1ñez, M Dueñas, ...
Journal of thrombosis and thrombolysis 22, 113-120, 2006
222006
Is veno-occlusive disease a specific syndrome or the exacerbation of physiopathologic hemostatic changes in hematopoietic stem cell transplantation (HSCT)?
L Villalón, AG Avello, J César, J Odriozola, J López, JP Oteyza, JG Laraña, ...
Thrombosis research 99 (5), 439-446, 2000
222000
Unraveling the heterogeneity of IgM monoclonal gammopathies: a gene mutational and gene expression study
C Jiménez, MI Prieto-Conde, M García-Álvarez, M Alcoceba, F Escalante, ...
Annals of Hematology 97, 475-484, 2018
212018
Emphysematous gastritis and severe aplastic anemia.
O Gutierrez, A Cantalapiedra, MI Tabuyo, R Del Villar, MJ Peñarrubia, ...
The Hematology Journal: the Official Journal of the European Haematology …, 2003
212003
Aspectos prácticos sobre el diagnóstico y tratamiento de las mastocitosis del adulto
L Escribano, P Bravo, A Cantalapiedra, R VASQUEZ CARNERO, ...
Actas dermo-sifiliográficas (Ed. impresa) 90 (5), 211-223, 1999
151999
Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens
T Castaño-Bonilla, JM Alonso-Dominguez, E Barragán, ...
Scientific Reports 11 (1), 20745, 2021
142021
Phase II trial of ofatumumab plus ESHAP (O‐ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first‐line chemotherapy
C Martínez, A Díaz‐López, M Rodriguez‐Calvillo, R García‐Sanz, ...
British Journal of Haematology 174 (6), 859-867, 2016
142016
Identification of relapse‐associated gene mutations by next‐generation sequencing in low‐risk acute myeloid leukaemia patients
MI Prieto‐Conde, C Jiménez, M García‐Álvarez, F Ramos, A Medina, ...
British Journal of Haematology 189 (4), 718-730, 2020
122020
Familial occurrence of primary antiphospholipid syndrome
A Cantalapiedra, AG Avello, JL Navarro, JM Cesar
Thrombosis research 95 (2), 127-129, 1999
111999
Novel agents as main drivers for continued improvement in survival in multiple myeloma
B Puertas, V González-Calle, E Sobejano-Fuertes, F Escalante, ...
Cancers 15 (5), 1558, 2023
92023
Mantle cell lymphoma with amyotrophic lateral sclerosis (motor neuron disease)
S Herrero, A Cantalapiedra, J Pérez-Oteyza, C Bellas, J Gobernado, ...
Haematologica 83 (4), 382-383, 1998
61998
Hematologic and cytogenetic response to lenalidomide in de novo acute myeloid leukemia with chromosome 5q deletion.
MJ Peñarrubia, LA Silvestre, J Conde, A Cantalapiedra, GF LJ
Leukemia research 33 (6), e8-9, 2009
52009
Estudio de incidencia de las neoplasias hematopoyéticas en Castilla y León
JA Rodríguez-García, L Vázquez, F Ramos, B Cuevas, A Martín, ...
Medicina Clínica 144 (11), 491-500, 2015
4*2015
Primary biliary cirrhosis," sicca" síndrome and autoimmune hemolytic anemia
A Cantalapiedra, MJ Penarrubia, O Gutierrez, F Garcia-Pajares, H Nunez, ...
Revista Espanola de Enfermedades Digestivas 97 (9), 678-679, 2005
42005
Estado de flujos de efectivo
AMT Cantalapiedra
Técnica contable 61 (719), 16-25, 2009
32009
El tratamiento contable de las existencias en las Normas Internacionales de Información Financiera
FM Carpio, AMT Cantalapiedra
Técnica contable 59 (701), 63-71, 2007
32007
Incidence of deep venous thrombosis associated with central venous catheters (DVT-CVC) in cancer patients: A multicenter study
J Feliu, R Lecumberri, A Jerez, A Cantalapiedra, T García, E Gonzalez, ...
Journal of Clinical Oncology 24 (18_suppl), 8627-8627, 2006
32006
Salvage treatment with ofatumumab and ESHAP (O-ESHAP) for patients with relapsed or refractory classical hodgkin's lymphoma after first-line chemotherapy: interim analysis of a …
C Martinez, M Rodriguez-Calvillo, MJ Terol, B Xicoy, R García-Sanz, ...
Blood 120 (21), 1630, 2012
22012
The system can't perform the operation now. Try again later.
Articles 1–20